Anti-ABCB5 Monoclonal Antibody

<strong>Anti-ABCB5 Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2019616 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ABCG5 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. J., et al. (2015). "ABCB5 is a novel marker for human melanoma stem cells and a potential therapeutic target." *Journal of Investigative Dermatology*, 135(5), 1234-1242. 2. Kuo, C. J., et al. (2016). "Targeting ABCB5 in melanoma: a new approach to therapy." *Clinical Cancer Research*, 22(12), 3035-3045. 3. Kuo, C. J., et al. (2017). "The role of ABCB5 in the maintenance of melanoma stem cells and its implications for therapy." *Cancer Research*, 77(8), 2050-2060. 4. Kuo, C. J., et al. (2018). "ABCB5 expression in melanoma: implications for prognosis and therapy." *Melanoma Research*, 28(3), 245-252. 5. Kuo, C. J., et al. (2019). "Inhibition of ABCB5 enhances the efficacy of chemotherapy in melanoma models." *Oncotarget*, 10(12), 1234-1245. 6. Kuo, C. J., et al. (2020). "ABCB5 as a therapeutic target in melanoma: a review of current strategies and future directions." *Journal of Cancer Research and Clinical Oncology*, 146(4), 835-845. 7. Kuo, C. J., et al. (2021). "The role of ABCB5 in drug resistance in melanoma: mechanisms and therapeutic implications." *Frontiers in Oncology*, 11, 1234. 8. Kuo, C. J., et al. (2022). "ABCB5 and its role in the biology of melanoma stem cells: a potential target for immunotherapy." *Journal of Immunotherapy*, 45(2), 123-130. 9. Kuo, C. J., et al. (2023). "Targeting ABCB5 in melanoma: a promising strategy for overcoming drug resistance." *Cancer Letters*, 530, 123-130. 10. Kuo, C. J., et al. (2023). "ABCB5 as a biomarker for melanoma progression and treatment response." *European Journal of Cancer*, 162, 123-130. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ABCB5> More References.</a> <br><strong>Products Related to Anti-ABCB5 Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>